PlainRecalls
FDA Drug Moderate Class II Terminated

Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41

Reported: February 14, 2024 Initiated: February 1, 2024 #D-0318-2024

Product Description

Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41

Reason for Recall

CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.

Details

Recalling Firm
NATCO Pharma Limited
Units Affected
4260 bottles
Distribution
Nationwide in the USA
Location
Rangareddy

Frequently Asked Questions

What product was recalled?
Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41. Recalled by NATCO Pharma Limited. Units affected: 4260 bottles.
Why was this product recalled?
CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 14, 2024. Severity: Moderate. Recall number: D-0318-2024.